Pfizer buys GBT, maker of sickle cell disease treatment; Carlyle CEO Kewsong Lee steps down abruptly

Carlyle's CEO Kewsong quits.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to read this article and more for free.

Share this